" class="no-js "lang="en-US"> Vifor Pharma - Medtech Alert
Monday, May 04, 2026
Vifor Pharma | Pharmtech Focus

Vifor Pharma

About Vifor Pharma

Vifor Pharma

Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care).

Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

For more information, please visit viforpharma.com

Vifor Pharma has set up this community to share with you news about the company and the current open positions. Sensitive topics, such as discussions about products or treatment options should be addressed privately with your physician. If you are concerned with an adverse event of a drug or a complaint regarding a product, please directly email safety@viforpharma.com or call +41 79 788 03 09.

Community Guidelines: https://bit.ly/3c4XIuO

As part of our commitment to you we will endeavour to ensure that the content on this page is positive and respectful. In doing so we ask that you respect our LinkedIn page guidelines which you find here: https://bit.ly/2P5Uvzj

Related Story

Caixa Capital Risc Leads Sale of Sanifit Therapeutics to Vifor Pharma with Upfront Payment of €205M

November 23 2021

Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its […]